|
|
| |
|
|
Symposium on Recent Advancements on Drug Discovery Science and Technology |
|
| |
|
Symposium on Novel Drug Delivery Systems and Technology |
|
| |
|
Symposium on New Discoveries and Achievements of Cancer Research |
|
| |
|
Symposium on Latest Advances in Cardiovascular Research and Therapeutics Development |
|
| |
|
Symposium on Innovation on CNS Research and Therapeutics Development |
|
| |
|
Symposium on Updates on Diabetes Research and Therapy |
|
|
| |
|
|
• Online Registration is Open
October 1st, 2019 |
|
• Call for speakers!
September 1st, 2019 |
|
• Welcome to the website of WCDI-2021
August 15th, 2019 |
|
|
| |
|
|
• Abstract Submission Start Day
September 1st, 2019 |
|
• Earlybird Registration Start Day
October 1st, 2019 |
|
• Earlybird Registration Deadline
December 31st, 2019
|
|
• Abstract Submission Deadline
June 30th, 2022
|
|
• Acceptance Notification Deadline
July 20 th, 2022 |
|
|
|
|
|
|
 |
Symposium on
Updates on Diabetes Research and Therapy |
|
| |
Introduction |
| Symposium on Updates on Diabetes Research and Therapy focuses on breaking through in Diabetes research and treatment. Diabetes is one among the greatest challenge in terms of healthcare management in most of the developed and developing countries of the modern world. With the best-in-class Speakers from the leading global Diabetes Institutions, we hope this symposium would help bring the latest and the best practices in Diabetes care to Clinicians treating people with Diabetes. |
Topics |
Session 6-1: Molecular Biology in Diabetes |
Session 6-2: Insulin Resistance and Beta Cell Biology |
Session 6-3: Diagnostics and Medical Devices in Diabetes |
Session 6-4: Emerging Diabetes Drugs and Drug Targets |
|
|
AGENDA
Day 0, August 11, 2021
Registration
Day 1, August 12, 2021
MORNING
Opening Ceremony
Welcome Remark by Honorary Chairs
Dr. Andreas Strasse, Fellow Of The Australian Academy of Science; NHMRC Senior Principal Research Fellow, Alan W Harris Personal Chair, Walter And Eliza Hall Institute of Medical Research, Australia
Dr. Chong-Su Cho, Fellow of Korean Academy of Science and Technology, Fellow of International Union of Societies for Biomaterials Science and Engineering; Research Professor, Research Institute for Agriculture and Life Sciences, Seoul National University, South Korea |
|
|
Keynote Forum I for Drug Discovery
|
|
|
|
Call for Chair |
|
|
Speech Time |
Speaker's Profile |
|
|
09:15-9:45 |
Title: GPCRomics: an approach to identify novel GPCR targets
Dr. Paul A. Insel, Distinguished Professor of Pharmacology and Distinguished Professor of Medicine, Co-Director, Medical Scientist (MD/PhD) Training Program, University of California, San Diego, USA |
|
|
09:45-10:15 |
Title: Inhibitors of Bruton’s tyrosine kinase (BTK) are transforming leukemia and lymphoma treatment
Dr. C. I. Edvard SMITH, Professor, Karolinska Institute, Sweden |
|
|
10:15-10:45 |
Title: Peptide Based Radiopahrmaceuticals for Cancer Diagnosis
Dr. Yueqing Gu, Professor, Biomedical Engineering; Dean, School of Engineering; Director, Molecular imaging
and Biomedical Engineering
China Pharmaceutical University, China |
|
|
10:45-11:00 |
Coffee Break |
|
|
11:00-11:30 |
Title: The Dawning of a New Era in Drug Discovery and Development
Dr. Richard Soll, Senior Vice President, Research Service Division, WuXi AppTec, USA |
|
|
11:30-12:00 |
Speech Opportunity Available |
|
|
Day 3, August 14, 2021
AFTERNOON
|
|
Symposium 6: Updates on Diabetes Research and Therapy
|
|
|
|
Dr. Colin G. Nichols, Carl Cori Professor Department of Cell Biology and Physiology, Washington University School of Medicine in St. Louis, USA |
|
|
Co-Chair |
Dr. Hongkai Gao, Director, Department of General Surgery, 3rd Medical Center, Chinese PLA General Hospital, China |
|
|
Speech Time |
Speaker's Profile |
|
|
13:30-13:55 |
Title: Excitation-secretion coupling in the beta cell: emerging issues and opportunities’
Dr. Colin G. Nichols, Carl Cori Professor Department of Cell Biology and Physiology, Washington University School of Medicine in St. Louis, USA
|
|
|
13:55-14:20 |
Title: Effect of gastric bypass on body fat distribution and expression of adiponectin, leptin in obesity patients with
T2DM
Dr. Hongkai Gao, Director, Department of General Surgery, 3rd Medical Center, Chinese PLA General Hospital, China |
|
|
| 14:20-14:45 |
Title: Endocrine Disrupting Chemicals as Unexpected Factors in the Type 2 Diabetes Pandemic
Dr. Bruce Blumberg, Professor, University of California, Irvine, USA |
|
|
14:45-15:10 |
Speech Opportunity Available |
|
|
15:10-15:30 |
Coffee Break |
|
|
|
|
